GSK3179106
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK3179106, covering 2017-01-18 to 2017-01-18. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I, Randomized, Placebo-controlled, Double Blind, Repeat Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Gastrointestinal Transit Time and Pharmacodynamic Biomarkers of GSK3179106 in Normal Subjects [Phase 1]